Open Medicine EU

Archives for Uncategorized

Nobody has a greater interest in access to clinical trial data than patients. Patients are exposed to the possibility of some risk, small it is hoped, when they enroll in a clinical trial and yet the sponsoring company owns the trial data and decides when, how, whether and to what extent the results are published.… » read more

Posted by Jim Murray

I covered previously the written question from Nessa Childers MEP arising from the extensive bribery of surgeons in Greece some years ago – see my earlier post here. The Commission has now given an answer, and it is bizarre. While the bribery was going on, certain orthopedic devices were twice as expensive in Greece compared… » read more

Posted by Jim Murray

I was irritated recently when I went to a presentation here in Brussels of a survey on off-label prescribing by the Irish Patients Association (IPA). I don’t blame the IPA for this – they presented a perfectly valid study, but I felt the meeting overall was serving another purpose or agenda. The survey, and the… » read more

Posted by Jim Murray

I’ve just read four papers on access to clinical trial data published in open access (no paywall) in “Circulation: Cardiovascular Quality and Outcomes”, a journal of the American Heart Association. One is a paper by Peter Gotsche, essentially a written version of his address to a seminar in the European Parliament which I covered in… » read more

Posted by Jim Murray

A “Hymn” to Science

Have a look here at a Youtube video that combines fun with good sense. I especially like the bit about living longer.

Posted by Jim Murray

I wrote a few times, most recently here, about payments for prescribing medical devices in Greece a few years ago. I see now on the website of the European Parliament a Written Question from Nessa Childers MEP on the subject, which reads as follows: “Legal proceedings in the US(1) and in the UK have disclosed… » read more

Posted by Jim Murray

In December, I argued for more transparency in relation to clinical trials, and hoped that the Commission would take up this issue in the forthcoming revision of the Clinical Trials Directive. I thought it might be useful to look at particular cases where more or earlier transparency might have saved lives or reduced harm. Take… » read more

Posted by Jim Murray

MEDICAL DEVICES

In some previous posts, here and here, I described how (prior to 2006) orthopaedic surgeons in Greece were paid to prescribe particular medical devices such as knee and hip replacements. The bribery was first uncovered under the Foreign Corrupt Practices Act in the US. This was followed by action by the UK Serious Fraud Office… » read more

Posted by Jim Murray

At an award ceremony a few days ago, the overall winners of the 2011 EU Health Prize for Journalists were Ben Hirschler and Kate Kelland from the UK, with an article on antimicrobial resistance “When the drugs don’t work”. The second prize went to Rita Makarész from Hungary for her article “The cheapest antidepressant”. The… » read more

Posted by Jim Murray

I’ve been looking at DG Sanco’s plans for medicines for 2012, and I am disappointed. Two years ago, DG Sanco took over the medicines dossier in the European Commission from DG Enterprise. Many people, myself included, had argued for years for such a transfer – to separate responsibility for medicines from responsibility for promoting the… » read more

Posted by Jim Murray